Skip to main content
Caplight Logo









Rhinal Therapeutics

Rhinal Therapeutics

Private
Las Vegas, NevadaHealthcare & Life Scienceshttps://rhinaltherapeutics.com/

Last Round

Angel

Aug 7, 2025

Total Funding Raised

$20,000

Company Overview

Rhinal Therapeutics is a healthtech company that develops nasal device technology for the delivery of intranasal dry powder GLP-1 treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

intranasal drug deliverynasal delivery devicedry powder inhalerGLP-1 deliverymedication adherencedrug bioavailabilitymedical device licensingnasal spray alternativeneedle-free injectiondrug delivery platformnasal drug deliverymedtechbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rhinal Therapeutics Comparables

Compare Rhinal Therapeutics with similar companies based on industry and business-model similarity.

Rhinal Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Therakind Ltd
83%
Zeteo Biomedical
82%
AptarGroup
72%

Rhinal Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelAug 7, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 7, 2025

    $20K raised in an angel round.

Rhinal Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rhinal Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rhinal Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLas Vegas, Nevada
Year Founded2023
Last FundingAug 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?